NEW YORK–(BUSINESS WIRE)–Netscribes,
Inc., a global market intelligence firm, released its Global
Interventional Cardiology Market report today. According to
Netscribes, the global interventional cardiology market will grow at an
overall compound annual growth rate (CAGR) of 6.9% until 2022 and will
be worth USD 21.88 billion by 2022.
Increasing incidences of cardiovascular diseases, growth in healthcare
spending, and rising adoption of interventional cardiology procedures
has led to the rise in demand for interventional cardiology across the
world. However, the market is yet to achieve full potential due to
challenges such as low accessibility in emerging economies, high
incidences of post-procedural complexities, such as thrombosis, and weak
spending on research and development in developing economies like India.
Despite the challenges, growth in the global interventional cardiology
market is promising. Major players such as Medtronic PLC, Abbott
Laboratories, and Boston Scientific Corporation are entering untapped
markets outside the purview of the developed economies, while further
expanding the business in their area of operations.
Key highlights from the report:
In the global interventional cardiology market, Medtronic PLC has the
highest market share followed by Abbott Laboratories. These two
players occupy half of the total market share globally.
North America has the highest share in the global interventional
cardiology market, followed by Asia-Pacific.
Increased adoption of the concept of ‘health promotion’ has led
patients to opt for surgeries at a much earlier stages of their
disease, which in turn has increased success rates of interventional
The development of advanced minimally invasive procedures and is
increased adoption in interventional cardiology is likely to drive the
global market in the future.
For more information, download the Netscribes Global
Interventional Cardiology Market Report.
Netscribes offers custom market research solutions based on specific
business needs. To request for custom research contact firstname.lastname@example.org.
Netscribes is a global market intelligence and content management firm
with services across the research and information value chain.
Netscribes provides tactical and actionable insights to its clients and
enables effective decision-making and strategic implementation. For more
information, visit www.netscribes.com.
Article source: http://www.businesswire.com/news/home/20180213005709/en/Global-Interventional-Cardiology-Market-Worth-USD-21.88/?feedref=JjAwJuNHiystnCoBq_hl-aC45ZVAsfQfjy4iJM4P87A1-eIfwn0x0eiSlv8DaAkIg_EfkFOaNgL2PG4SPbr1kg_A2CGL-EyAtYNbtACnGnJ51YlY7W-9mzj-PuJxyuYnS-XfqwrefcF50_QVKGoICg==